Strength
262 mg/1
Manufacturer
McKessonNDC
68599474407
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISMUTH SUBSALICYLATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M008On Market Since
3/1/2022
Price Statistics
The NADAC for BISMUTH 262 MG TABLET CHEW has been published 95 times since Dec 11, 2024, and over the history we have for it it has risen 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0817 per EA |
|---|---|
| All-time high | $0.0854 (Dec 10, 2025) |
| All-time low | $0.0739 (Dec 11, 2024) |
| 52-week high | $0.0854 |
| 52-week low | $0.0809 |
| Median price | $0.0826 |
| Average price | $0.0819 |
| Largest weekly change | +5.5% (Feb 19, 2025) |
| Weeks tracked | 95 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the bismuth subsalicylate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
McKesson manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bismuth subsalicylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BISMUTH 262 MG TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for BISMUTH 262 MG TABLET CHEW, manufactured by McKesson, is $0.0817 per EA (NDC 68599474407), effective Sep 30, 2026.
How has the price of BISMUTH 262 MG TABLET CHEW changed over time?
Over the history we have for it, the NADAC for BISMUTH 262 MG TABLET CHEW has risen 10.5%. It has been tracked across 95 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for BISMUTH 262 MG TABLET CHEW?
Since Dec 11, 2024, the NADAC for BISMUTH 262 MG TABLET CHEW has ranged from a low of $0.0739 (Dec 11, 2024) to a high of $0.0854 (Dec 10, 2025), with a median of $0.0826 per EA.
Are there cheaper alternatives to BISMUTH 262 MG TABLET CHEW?
No other NADAC-published product currently shares the active ingredient and strength of BISMUTH 262 MG TABLET CHEW in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BISMUTH 262 MG TABLET CHEW?
BISMUTH 262 MG TABLET CHEW (NDC 68599474407) is labeled by McKesson, and CMS classifies it as a generic product.